Cidara Therapeutics Inc
CDTX62.905USD
+0.005+0.01%
交易中 （美东）报价延迟15分钟
768.02M总市值
亏损市盈率 TTM
关于 Cidara Therapeutics Inc 公司
Cidara Therapeutics, Inc. 是一家生物技术公司。该公司正在开发针对严重疾病患者的靶向免疫疗法。该公司的产品组合包括各种治疗和预防范例，包括来自其 Cloudbreak 平台的针对肿瘤、病毒和自身免疫性疾病的药物-Fc 结合物 (DFC)。该公司专注于推进 Cloudbreak 开发项目，包括其领先的肿瘤候选药物 CBO421，以及推进其他管道资产。CBO421 是一种针对 CD73 的开发候选药物，用于治疗实体瘤。其先进的 DFC 项目是 CD388，这是一种高效抗病毒药物，旨在提供季节性和大流行性流感的普遍预防和治疗，目前处于 I 期和 IIa 期临床试验阶段。其其他项目针对多种自身免疫适应症。
公司简介
公司代码CDTX
公司名称Cidara Therapeutics Inc
上市日期Apr 15, 2015
CEODr. Jeffrey L. (Jeff) Stein, Ph.D.
员工数量38
证券类型Ordinary Share
年结日Apr 15
公司地址6310 Nancy Ridge Dr Ste 101
城市SAN DIEGO
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编92121-3209
电话18587526170
网址https://www.cidara.com/
公司代码CDTX
上市日期Apr 15, 2015
CEODr. Jeffrey L. (Jeff) Stein, Ph.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Frank L. Karbe
Mr. Frank L. Karbe
Chief Financial Officer
Chief Financial Officer
57.50K
--
Mr. Daniel D. (Dan) Burgess
Mr. Daniel D. (Dan) Burgess
Independent Chairman of the Board
Independent Chairman of the Board
150.00
--
Mr. Ryan Spencer
Mr. Ryan Spencer
Independent Director
Independent Director
--
--
Dr. Bonnie Bassler, Ph.D.
Dr. Bonnie Bassler, Ph.D.
Independent Director
Independent Director
--
--
Ms. Chrysa Mineo
Ms. Chrysa Mineo
Independent Director
Independent Director
--
--
Dr. Jeffrey L. (Jeff) Stein, Ph.D.
Dr. Jeffrey L. (Jeff) Stein, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Brian Ritchie
Mr. Brian Ritchie
Investor Relations
Investor Relations
--
--
Mr. Theodore R. (Ted) Schroeder
Mr. Theodore R. (Ted) Schroeder
Independent Director
Independent Director
--
--
Mr. Shane Ward
Mr. Shane Ward
Chief Operating Officer, Chief Legal Officer, Company Secretary
Chief Operating Officer, Chief Legal Officer, Company Secretary
--
--
Dr. Josh Resnick, M.D., J.D.
Dr. Josh Resnick, M.D., J.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Frank L. Karbe
Mr. Frank L. Karbe
Chief Financial Officer
Chief Financial Officer
57.50K
--
Mr. Daniel D. (Dan) Burgess
Mr. Daniel D. (Dan) Burgess
Independent Chairman of the Board
Independent Chairman of the Board
150.00
--
Mr. Ryan Spencer
Mr. Ryan Spencer
Independent Director
Independent Director
--
--
Dr. Bonnie Bassler, Ph.D.
Dr. Bonnie Bassler, Ph.D.
Independent Director
Independent Director
--
--
Ms. Chrysa Mineo
Ms. Chrysa Mineo
Independent Director
Independent Director
--
--
Dr. Jeffrey L. (Jeff) Stein, Ph.D.
Dr. Jeffrey L. (Jeff) Stein, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 8月2日 周六
更新时间: 8月2日 周六
持股股东
股东类型
持股股东
持股股东
占比
RA Capital Management, LP
16.69%
Commodore Capital LP
5.83%
VR Adviser, LLC
5.21%
TCG Crossover Management, LLC
4.99%
Point72 Asset Management, L.P.
4.96%
Other
62.32%
持股股东
持股股东
占比
RA Capital Management, LP
16.69%
Commodore Capital LP
5.83%
VR Adviser, LLC
5.21%
TCG Crossover Management, LLC
4.99%
Point72 Asset Management, L.P.
4.96%
Other
62.32%
股东类型
持股股东
占比
Venture Capital
29.07%
Hedge Fund
24.64%
Investment Advisor
15.03%
Investment Advisor/Hedge Fund
4.77%
Individual Investor
1.12%
Research Firm
0.52%
Pension Fund
0.12%
Other
24.73%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
130
15.18M
75.27%
+7.25M
2025Q1
124
10.47M
53.54%
+2.71M
2024Q4
122
7.70M
70.35%
+1.07M
2024Q3
109
4.49M
61.04%
+771.77K
2024Q2
109
1.90M
39.70%
+56.88K
2024Q1
108
1.55M
384.06%
-209.94K
2023Q4
111
1.70M
37.69%
-299.58K
2023Q3
119
1.90M
42.77%
-451.34K
2023Q2
126
1.95M
43.98%
-451.51K
2023Q1
153
2.02M
47.21%
-214.92K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
RA Capital Management, LP
3.37M
16.69%
+2.27M
+207.97%
Jun 26, 2025
Commodore Capital LP
1.18M
5.83%
+1.18M
--
Jun 25, 2025
VR Adviser, LLC
1.05M
5.21%
+285.80K
+37.32%
Mar 31, 2025
TCG Crossover Management, LLC
1.01M
4.99%
--
--
Mar 31, 2025
Point72 Asset Management, L.P.
999.41K
4.96%
+885.56K
+777.80%
Apr 09, 2025
Adage Capital Management, L.P.
990.00K
4.91%
+620.05K
+167.60%
Mar 31, 2025
BVF Partners L.P.
924.64K
4.59%
-168.15K
-15.39%
Mar 31, 2025
Bain Capital Life Sciences Investors, LLC
703.08K
3.49%
--
--
Mar 31, 2025
Canaan Partners
703.08K
3.49%
+703.08K
--
Jul 19, 2024
Vivo Capital, LLC
684.28K
3.39%
+13.68K
+2.04%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
Invesco Dorsey Wright SmallCap Momentum ETF
0.78%
iShares Micro-Cap ETF
0.15%
Avantis US Small Cap Equity ETF
0.05%
iShares Russell 2000 Value ETF
0.05%
Proshares Ultra Russell 2000
0.03%
ProShares UltraPro Russell2000
0.03%
Global X Russell 2000 ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
ProShares Hedge Replication ETF
0.03%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
查看更多
Invesco Dorsey Wright SmallCap Momentum ETF
占比0.78%
iShares Micro-Cap ETF
占比0.15%
Avantis US Small Cap Equity ETF
占比0.05%
iShares Russell 2000 Value ETF
占比0.05%
Proshares Ultra Russell 2000
占比0.03%
ProShares UltraPro Russell2000
占比0.03%
Global X Russell 2000 ETF
占比0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.03%
ProShares Hedge Replication ETF
占比0.03%
Invesco RAFI US 1500 Small-Mid ETF
占比0.02%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Apr 22, 2024
Merger
20<1
Apr 22, 2024
Merger
20<1
Apr 22, 2024
Merger
20<1
Apr 22, 2024
Merger
20<1
公告日期
类型
比率
Apr 22, 2024
Merger
20<1
Apr 22, 2024
Merger
20<1
Apr 22, 2024
Merger
20<1
Apr 22, 2024
Merger
20<1
